These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6468179)

  • 1. Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.
    Ewers SB; Långström E; Baldetorp B; Killander D
    Cytometry; 1984 Jul; 5(4):408-19. PubMed ID: 6468179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
    Hedley DW; Rugg CA; Ng AB; Taylor IW
    Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the malignancy of breast carcinoma using flow cytometry].
    Ueki H; Abe R; Kimura M; Kasai M
    Gan No Rinsho; 1985 Jul; 31(8):929-32. PubMed ID: 2993696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG; Schmidt A; Nehls O; Kaiser S
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric detection of multifocal DNA aneuploid cell populations in mastectomy specimens containing a primary breast carcinoma.
    van Dam PA; Van Bockstaele DR; Keersmaeckers GH; Uyttenbroeck FL
    Cytometry; 1990; 11(2):300-7. PubMed ID: 2318083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.
    Frankfurt OS; Slocum HK; Rustum YM; Arbuck SG; Pavelic ZP; Petrelli N; Huben RP; Pontes EJ; Greco WR
    Cytometry; 1984 Jan; 5(1):71-80. PubMed ID: 6199167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA analysis in advanced breast cancer.
    Leivonen M; Krogerus L; Nordling S
    Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy of human breast cancer.
    Del Bino G; Silvestrini R; Zucconi MR; Marchese G; Valentinis B; Di Fronzo G; Andreola S
    Anal Cell Pathol; 1989 Aug; 1(4):215-23. PubMed ID: 2487046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
    Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
    Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
    Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.